Transformational Quarter Marked by Clinical Validation, Regulatory Progress, and Strategic Momentum in Commercial AI Platform Launch. LP-184 Phase 1a clinical trial results demons ...
Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced financial results for the third quarter ...
Q3 2025 Earnings Call Transcript November 12, 2025 Valens Semiconductor Ltd. misses on earnings expectations. Reported EPS is ...
DoorDash, Inc. ( DASH) Morgan Stanley 25th European Technology, Media & Telecom Conference November 13, 2025 11:00 AM EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback